An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees

OBJECTIVES: A specific and sensitive automated chemiluminescent immunoassay (CLIA) was developed to detect neutralizing antibody (NAb) levels. This assay can be used for the diagnosis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, treatment and vaccine evaluation. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Binjian, Su, Xibin, Yu, George, Yang, Shuling, Wang, Feng, Huang, Tao, Zhou, Liuyong, Hui, Zhiqiang, Liao, Yixian, Qiu, Yuan, Huang, Juan, Gao, Hong, Liu, Justin, Zhong, Yaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660141/
https://www.ncbi.nlm.nih.gov/pubmed/34896578
http://dx.doi.org/10.1016/j.ijid.2021.12.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660141/
https://www.ncbi.nlm.nih.gov/pubmed/34896578
http://dx.doi.org/10.1016/j.ijid.2021.12.316

Ejemplares similares